A chemical strategy to manipulate the intracellular localization of drugs in resistant cancer cells

Biochemistry

Volumn 44, Issue 48, 2005, Pages 15743-15749

  Duvvuri, Muralikrishna ^a   Konkar, Samidha ^a   Funk, Ryan S ^a   Krise, Joanna M ^a   Krise, Jeffrey P ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MEMBRANES; CELLS; ISOMERS; MATHEMATICAL MODELS; ONCOLOGY; PROTEINS; TUMORS;

ANTICANCER AGENTS; LYSOSOMES; MULTIDRUG-RESISTANT (MDR) CANCER CELLS; PLASMA MEMBRANES;

DRUG PRODUCTS;

1 AMINOISOQUINOLINE; 3 AMINOQUINOLINE; 4 AMINOQUINOLINE; 5 AMINOISOQUINOLINE; 8 AMINOQUINOLINE DERIVATIVE; AMINE; ANTINEOPLASTIC AGENT; CARRIER PROTEIN; DAUNORUBICIN; GLYCOPROTEIN P; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ALKALINITY; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL COMPARTMENTALIZATION; CELL MEMBRANE; CELL NUCLEUS; CELL STRAIN HL 60; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IC 50; ISOMER; LYSOSOME; MULTIDRUG RESISTANCE; PKA; PRIORITY JOURNAL;

CELL COMPARTMENTATION; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HL-60 CELLS; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LYSOSOMES; MICROSCOPY, FLUORESCENCE;

EID: 28544443286     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi051759w     Document Type: Article

References (29)

1. Gottesman, M. M. (2002) Mechanisms of cancer drug resistance, Annu. Rev. Med. 53, 615-627.
2. Leonessa, F., an Clarke, R. (2003) ATP binding cassette transporters and drug resistance in breast cancer, Endocr. Relat. Cancer 10, 43-73.
3. Slapak, C. A., Lecerf, J. M., Daniel, J. C., and Levy, S. B. (1992) Energy-dependent accumulation of daunorubicin into subcellular compartments of human leukemia cells and cytoplasts, J. Biol. Chem. 267, 10638-10644.
4. Slapak, C. A., Mizunuma, N., and Kufe, D. W. (1994) Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells, Blood 84, 3113-3121.
5. Oza, A. M. (2002) Clinical development of P glycoprotein modulators in oncology, Novartis Found. Symp. 243, 103-115 (discussion 115-118, 180-185).
6. Grey, M., Borg, A. G., Wood, P., Burgess, R., Fisher, A., and Yin, J. A. (1997) Effect on cell kill of addition of multidrug resistance modifiers cyclosporin A and PSC 833 to cytotoxic agents in acute myeloid leukaemia, Leuk. Res. 21, 867-874.
7. Rajagopal, A., and Simon, S. M. (2003) Subcellular localization and activity of multidrug resistance proteins, Mol. Biol. Cell 14, 3389-3399.
8. Larsen, A. K., Escargueil, A. E., and Skladanowski, A. (2000) Resistance mechanisms associated with altered intracellular distribution of anticancer agents. Phamacol. Ther. 85, 217-229.
9. Duvvuri, M., and Krise, J. P. (2005) Intracellular drug sequestration events associated with the emergence of multidrug resistance: a mechanistic review, Front. Biosci. 10, 1499-1509.
10. Gong, Y., Duvvuri, M., and Krise, J. P. (2003) Separate roles for the Golgi apparatus and lysosomes in the sequestration of drugs in the multidrug-resislanl human leukemic cell line HL-60, J. Biol. Chem. 278, 50234-50239.
11. Altan, N., Chen, Y., Schindler, M., and Simon, S. M. (1998) Defective acidification in human breast tumor cells and implications for chemotherapy, J. Exp. Med. 187, 1583-1598.
12. de Duve, C., de Barsy, T., Poole, B., Trouet, A., Tulkens, P., and Van Hoof, F. (1974) Commentary. Lysosomotropic agents, Biochem. Pharmacol. 23, 2495-2531.
13. Ferrao, P., Sincock, P., Cole, S., and Ashman, L. (2001) Intracellular P-gp contributes to functional drug efflux and resistance in acute myeloid leukaemia, Leuk. Res. 25, 395-405.
14. Davies, J. P., Chen, F. W., and Ioannou, Y. A. (2000) Transmembrane molecular pump activity of Niemann-Pick Cl protein, Science 290, 2295-2298.
15. Reijngoud, D. J., and Tager, J. M. (1977) The permeability properties of the lysosomal membrane, Biochim. Biophys. Acta 472, 419-449.
16. Bulychev, A., Trouet, A., and Tulkens, P. (1978) Uptake and intracellular distribution of neutral red in cultured fibroblasts, Exp. Cell. Res. 115, 343-355.
17. Stone, A. L., and Bradley, D. F. (1967) Aggregation of cationic dyes on acid polysaccharides. I. Spectrophotometric titration with acridine orange and other metachromatic dyes, Biochim. Biophys. Acta 148, 172-192.
18. Israel, M., Taube, D., Seshadri, R., and Idriss, J. M. (1986) Adriamycin analogues. Preparation and biological evaluation of some H-(trifluoroacetyl)-14- O-[(N-acetylamino)acyl]adriamycin derivatives, J. Med. Chem. 29, 1273-1276.
19. 2O, J. Inorg. Biochem. 98, 161-166.
20. Perrin, D. D. (1965) Dissociation constants of organic bases in aqueous solution, Butterworth & Co., London.
21. Duvvuri, M., Gong, Y., Chatterji, D., and Krise, J. P. (2004) Weak base permeability characteristics influence the intracellular sequestration site in the multidrug-resistant human leukemic cell line HL-60, J. Biol. Chem. 279, 32367-32372.
22. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods 65, 55-63.
23. Duvvuri, M., Feng, W., Mathis, A., and Krise, J. P. (2004) A cell fractionation approach for the quantitative analysis of subcellular drug disposition, Pharm. Res. 21, 26-32.
24. Diettrich, O., Mills, K., Johnson, A. W., Hasilik, A., and Winchester, B. G. (1998) Application of magnetic chromatography to the isolation of lysosomes from fibroblasts of patients with lysosomal storage disorders, FEBS Lett. 441, 369-372.
25. Duvvuri, M., and Krise, J. P. (2005) A novel assay reveals that weakly basic model compounds concentrate in lysosomes to an extent greater than pH-partitioning theory would predict, Mol. Pharm. (in press).
26. Altan, N., Chen, Y., Schindler, M., and Simon, S. M. (1999) Tamoxifen inhibits acidificalion in cells independent of the estrogen receptor, Proc. Natl. Acad. Sci. U.S.A. 96, 4432-4437.
27. Bundgaard, H., and Johansen, M. (1980) Prodrugs as drug delivery systems IV: N-Mannich bases as potential novel prodrugs for amides, ureides, amines, and other NH-acidic compounds, J. Pharm. Sci. 69, 44-46.
28. Cogan, P., Fowler, C., Post, G., and Koch, T. (2004) Doxsaliform: A novel N-mannich base prodrug of a doxorubicin formaldehyde conjugate, Lett. Drug Des. Discovery 1, 247-255.
29. Chaires, J. B., Salyanarayana, S., Suh, D., Fokt, I., Przewloka, T., and Priebe, W. (1996) Parsing the free energy of anthracycline antibiotic binding to DNA, Biochemistry 35, 2047-2053.